Indian equities enter Monday’s session with a long list of stock-specific triggers, even as the broader Nifty 50 continues searching for a decisive breakout. The index ended the previous session almost flat after a volatile move, and analysts are watching whether it can hold above 24,000 and push past the 24,200 resistance zone.
A sustained move above 24,200 could strengthen upward momentum and open the door for a rally towards the 24,400–24,600 region. Until that level is reclaimed, stock-specific catalysts will drive returns.
For today’s trade, Waaree Energies, Kotak Mahindra Bank, HDFC Bank, Persistent Systems, Strides Pharma, Tata Motors Passenger Vehicles, Adani Green Energy, PTC Industries and Alembic Pharmaceuticals are in focus due to regulatory updates, leadership changes, deal announcements, USFDA approvals and capacity expansion news.
Top Stocks In News Today
| Stock | Trigger | Why It Matters |
|---|---|---|
| Waaree Energies | US CBP clears Chinese cell allegation; AD/CVD duties imposed | Trade compliance and US export revenue at risk |
| Kotak Mahindra Bank | CEO Ashok Vaswani to step down after Dec 31, 2026 | Leadership succession becomes key investor focus |
| HDFC Bank | External legal review clears bank; ex-chairman disputes findings | Governance and succession risk for index heavyweight |
| Persistent Systems | $650M, 6.5-year cloud services deal secured | Strong revenue visibility; $125M+ ACV annually |
| Strides Pharma | Pivot Path stake sold for ₹100 crore to Ascent Capital | Value unlock; ₹230 crore post-money valuation |
| Tata Motors PV | 4 new EVs + 10 refreshes planned by FY31 | Aggressive push to defend EV market leadership |
| Adani Green | 150 MW Khavda solar project operationalised | Total renewable capacity touches 19,985.8 MW |
| PTC Industries | ₹1,800 crore fundraise approved via QIP/preferential issue | Growth capital and balance sheet expansion in focus |
| Alembic Pharma | USFDA final approval for Oseltamivir oral suspension | Adds to US generics pipeline |
Waaree Energies: US Probe Relief, But 271.28% AD/CVD Duties Loom
Waaree Energies clarified that the US Customs and Border Protection (CBP) found no evidence that the company exported solar modules manufactured using Chinese-origin solar cells to the US, and that the investigation was limited to certain historical imports.
Following a detailed investigation, including an on-site verification of Waaree’s manufacturing facility in India, CBP confirmed that Waaree fully cooperated, drew no adverse inference against the company, and declined the petitioner’s request to make an evasion finding covering all of Waaree’s imports.
However, the matter does not end here. The CBP’s June 23, 2026 determination also found that Waaree had evaded anti-dumping and countervailing duties on solar cells imported from Vietnam and Malaysia between 2021 and June 2026, resulting in anti-dumping duties of up to 271.28% on the implicated solar modules.
Waaree stated the decision is not final and is evaluating legal options, including a de novo administrative review and judicial review before the US Court of International Trade. CEO Jignesh Rathod confirmed the company is evaluating all available legal remedies with its US trade counsel.
Waaree is India’s largest solar PV module manufacturer with a US manufacturing facility. The US market remains both its biggest growth driver and its most significant regulatory risk variable for investors.
Kotak Mahindra Bank: CEO Exit Puts Succession In Focus
Kotak Mahindra Bank will be in focus after MD and CEO Ashok Vaswani confirmed he will not seek reappointment after his current term ends on December 31, 2026, citing personal reasons. The bank has begun the process of identifying a successor.
The development comes at a sensitive time for Kotak, which has been working to deploy surplus capital, accelerate loan growth and improve return metrics. The exit is not abrupt, giving the board time for an orderly transition.
However, large private banks trade partly on leadership clarity and execution confidence, making the succession timeline a key variable investors will track closely through the second half of 2026.
HDFC Bank: Legal Review Clears Bank, But Governance Battle Continues
HDFC Bank said on June 26 that an external legal review conducted by US law firm Wilson Sonsini Goodrich & Rosati and Indian law firm Wadia Ghandy & Co. found no evidence to substantiate the concerns raised by former chairman Atanu Chakraborty in his resignation letter, following a three-month examination of thousands of documents and interviews with independent directors and senior management.
Chakraborty had resigned as part-time chairman and independent director on March 18, 2026, stating certain happenings and practices within the bank over the previous two years were not in congruence with his personal values and ethics.
Chakraborty has since rejected the bank’s claims that he failed to cooperate, asserting the probe was a “roving inquiry” and an “exercise in futility,” adding that he repeatedly requested the specific terms of reference and legal framework under which the external lawyers were operating.
HDFC Bank shares remain down over 5.5% from their March 18 close, currently near Rs 796. With the legal review concluded, analysts say the bank must now focus on succession planning — including the appointment of a new part-time chairman and potential re-appointment of MD and CEO Sashidhar Jagdishan, whose term ends in October 2026.
Persistent Systems: $650M Deal Signals Multi-Year Revenue Runway
Persistent Systems has entered into a 6.5-year strategic services agreement worth over $650 million with a US-based global technology leader, with an annual contract value exceeding $125 million. The contract covers product development, cloud services operations and support, and the company confirmed the deal is not a related party transaction and falls within the ordinary course of business.
The agreement expands the company’s presence across North America, Europe and Asia Pacific. This comes alongside a second major development: Persistent Systems has signed a Business Combination Agreement to acquire Nagarro SE, with its wholly-owned subsidiary Galaxy Germany Holding SE set to launch a voluntary public takeover offer for all outstanding Nagarro shares at EUR 81.00 per share — a premium of approximately 140% to the undisturbed closing price on June 25, 2026. The transaction is expected to close in Q4 CY2026 or Q1 CY2027, subject to regulatory approvals.
Together, the $650M deal and the Nagarro acquisition make Persistent one of the most aggressively expanding mid-cap IT names in the current cycle.
Strides Pharma: Pivot Path Valued at ₹230 Crore in Ascent Capital Deal
Strides Pharma Science has agreed to sell a majority stake in its technology services subsidiary Pivot Path to a consortium led by Ascent Capital, in a transaction that values the business at ₹230 crore on a post-money basis. Strides will realise approximately ₹100 crore while retaining an approximately 20% stake. Pivot Path will also receive a ₹50 crore primary capital infusion to fund expansion and investments in AI-led platforms.
The consideration will be received in two tranches: ₹75 crore at initial closing and ₹25 crore on the first anniversary of closing. For FY26, Pivot Path reported revenue of ₹144.7 crore and EBITDA of ₹16.9 crore. Following the transaction, Pivot Path will be reclassified from a wholly owned subsidiary to an associate company of Strides.
Other Stocks To Track
| Stock | Development |
|---|---|
| Tata Motors PV | 4 new EV products and 10+ refreshes planned by FY31; targeting revenue nearly double current levels |
| Adani Green | 150 MW Khavda solar project operational; total renewable capacity 19,985.8 MW; BESS capacity 3,366 MWh |
| PTC Industries | Board approved raising up to ₹1,800 crore via QIP/preferential issue; borrowing limit raised to ₹600 crore from ₹350 crore |
| Alembic Pharma | USFDA final approval for Oseltamivir Phosphate oral suspension 6 mg/mL for influenza A and B |
What Investors Should Watch Today
| Stock | Key Level / Trigger | Forward Watch |
|---|---|---|
| Nifty 50 | Decisive close above 24,200 | 200-DMA at ~24,500 next target |
| Waaree Energies | US AD/CVD legal outcome | Anti-dumping duties up to 271.28% on historical imports |
| Kotak Mahindra Bank | Successor announcement timeline | CEO transition by Dec 31, 2026 |
| HDFC Bank | Jagdishan reappointment | Term ends October 2026 |
| Persistent Systems | $650M deal ramp-up pace | ACV of $125M+ annually |
| Strides Pharma | Pivot Path closing date | ₹75 crore receivable at initial closing |
The week’s key market signal remains the Nifty’s ability to post a decisive close above 24,200. Until that level is reclaimed on a closing basis, fresh corporate triggers, not index momentum, will determine where money moves in Monday’s session.
